Abbott Vascular Medical Device Registry

The AV-MDR is a prospective, non-randomized, open-label, multi-center registry. The purpose of the AV-MDR study is to proactively collect and evaluate clinical data on the usage of the devices in scope within their intended use with the aim of confirming safety and performance throughout their expected lifetime, ensuring the continued acceptability of identified risks, detecting emerging risks on the basis of factual evidence, ensuring the continued acceptability of the benefit-risk ratio, and identifying possible systematic misuse or off-label usage such that the intended use can be verified as appropriate.

NCT Number	NCT04573660
Lead Sponsor	Abbott Medical Devices
Conditions	Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism, Arterial Embolism
Enrollment	3,784 participants
Start Date	2020-10-25
Primary Completion	2030-11 (estimated)
Study Completion	2031-11 (estimated)
Updated on ClinicalTrials.gov	2025-07-03